Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


INORGANIC ACTIVE INGREDIENT CONTAINING

Subclass of:

424 - Drug, bio-affecting and body treating compositions

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
424617000 Heavy metal or compound thereof 907
424601000 Phosphorus or phosphorus compound 200
424613000 Peroxide or compositions of or releasing gaseous oxygen or ozone 165
424682000 Aluminum, calcium or magnesium element, or compound containing 158
424661000 Elemental chlorine or elemental chlorine releasing inorganic compound (e.g., chlorties, hypochlorites, etc.) 109
424722000 Alkali metal or alkaline earth containing 94
424677000 Alkali or alkaline earth chloride (e.g., barium or lithium chloride, etc.) 80
424718000 Nitrates or nitrites or nitric acid or nitrogen oxides 73
424703000 Elemental sulfur or compound thereof 45
424702000 Selenium or compound thereof 41
424715000 Carbonate 40
424657000 Boron 27
424667000 Elemental iodine or iodine compound 26
424699000 Carbon disulfide, monoxide, or dioxide 21
424719000 Ammonia or ammonium compound containing 12
424724000 Silicon dioxide containing 10
424666000 Hydrochloric acid 8
424607000 Hydrogen metal cyanide, cyanide, cyanate, or thio analog thereof 8
424673000 Elemental fluorine or fluorine compound 6
424723000 Elemental bromine or bromine compound containing 6
Entries
DocumentTitleDate
20120201900SYSTEMS, METHODS, AND DEVICES FOR MICROBUBBLES - A suspension of gas-filled microbubbles can be synthesized by sonicating a lipid solution and a first gas in a reaction volume. The resulting microbubble suspension can be stored for later use, for example, for infusion into a patient for gas delivery thereto. Various techniques can improve the shelf life of the microbubbles. For example, the microbubble suspension can be freeze-dried to remove water and the first gas therefrom while leaving the microbubble shells intact. In an alternative, the microbubble suspension can be frozen. In still another alternative, the microbubble suspension can be formed with a first gas that has a low solubility, thereby creating microbubbles with increased stability. Prior to use, the microbubble suspension can be prepared by exchanging the gas in the microbubble cores, rehydrating, and/or raising the temperature of the stored microbubbles.08-09-2012
20100143488PROMOTER OF HARD TISSUE REGENERATION - The object of the present invention is to provide a hard-tissue regeneration promoter, a pharmaceutical composition, a food composition, a food, etc., useful for regeneration of an impaired or defective hard tissue, which can be prepared in low production and labor costs. That is, regeneration of a hard tissue in an impaired or defective area can be promoted by causing such an agent or composition to contain diatomaceous earth and administering the resulting agent/composition beneath the periosteum in the vicinity of the impaired or defective hard tissue or orally administering the same.06-10-2010
20080260855Processed water and therapeutic uses thereof - A physiologically ingestible composition of matter obtained by preparing oxygenated water with a stable negative oxidation reduction potential (ORP), and the uses thereof, are provided. The obtaining method includes preconditioning water received from a water source for electrolysis, performing electrolysis on the preconditioned water, outputting alkaline water and/or acidic water with a stable negative ORP (“negative ORP water”), combining the negative ORP water with oxygen, and manipulating the combined negative ORP water and oxygen into a vortex so as to cause the oxygen to diffuse into the water. The output alkaline and/or acidic oxygenated water with a stable negative ORP may be used for a variety of purposes and/or applications. For example, the method may be utilized as part of a method for producing and tuning super-oxygenated and structured water. The physiologically ingestible composition of matter may be administered to treat infection in a mammal.10-23-2008
20100151041Hypersaturated gas in liquid - Dispersing a gas in a liquid to provide a mixture of saturated, supersaturated or hypersaturated solution to provide a suspension of bubbles containing gas therein.06-17-2010
20110195129WATER HAVING ANTICANCER ACTIVITY AND METHOD FOR MAKING THE SAME - To provide water that is able to suppress proliferation of cancer cells by taking it in the human body through ingestion or injection thereof and is free of side effects and a method for making same.08-11-2011
20130084343METHODS OF DETECTING SEPSIS - Methods of sepsis in a sample from a patient are provided. Methods of detecting changes in expression of one or more RNAs associated with sepsis are also provided. Compositions and kits are also provided.04-04-2013
20100074966Gaseous Mixture Containing O2 and N2O For Preventing Or Reducing Hyperalgesia - The invention relates to a gaseous mixture containing oxygen and nitrous oxide in a nitrous oxide proportion of between 5 and 15 vol. %, that can be used for producing a drug for preventing or reducing hyperalgesia in human beings or animals, in particular a post-operation opioid-induced hyperalgesia.03-25-2010
20100074965COSMETIC COMPOSITION COMPRISING A METEORITE EXTRACT, AND USE OF THE EXTRACT AS COSMETIC AGENT SUITABLE FOR STIMULATING THE DIFFERENTIATION OF HUMAN KERATINOCYTES - The present invention relates to a cosmetic composition comprising a meteorite extract. The present invention also relates to methods of using the extract as a cosmetic agent suitable for stimulating the differentiation of human keratinocytes.03-25-2010
20120244228CHLORINE DIOXIDE PRECURSOR AND METHODS OF USING SAME - According to one aspect of the invention, a method of converting an oxy halide salt into a halide dioxide in a reaction zone under certain conditions is provided. More specifically, the method includes generating chlorine dioxide from a stable composition comprising an oxy halide salt by introducing said composition to a reducing agent and minimum temperature within the reaction zone. According to another aspect of the invention, a composition for a stable chlorine dioxide precursor comprising an oxy halide salt is provided.09-27-2012
20090258085Emulsions and methods of their production - An emulsion including Dead Sea water is provided, as well as methods for making and using such an emulsion. The emulsion can also include a structured surfactant.10-15-2009
20130039993ARGON-BASED INHALABLE GASEOUS MEDICAMENT AGAINST PERIPHERAL ORGAN DEFICIENCIES OR FAILURES - The invention relates to a gaseous composition containing an effective amount of argon gas for use, by inhalation, in preventing or treating a deficiency or failure of at least one peripheral organ in a patient. Preferably, it contains between 15 and 80% by volume of argon, and oxygen, preferably at least 21% by volume of oxygen. The organ deficiency or failure thus treated is transient, preferably from less than one hour to a plurality of days or weeks, or definitive. The organ concerned may be the liver, the kidneys or the lungs.02-14-2013
20130209573EFFICIENT, CATALYTIC AND SCALABLE METHOD TO PRODUCE CHLORINE DIOXIDE - Methods, kits, cartridges and compounds related to generating chlorine dioxide by exposing ClO08-15-2013
20100062074ALLERGEN INACTIVATING AGENT - An allergen inactivating agent for preventing allergic manifestations or alleviating symptoms by reducing antigenicity of an allergen through contact with the allergen includes dissolved chlorine dioxide as an active ingredient.03-11-2010
20100330193METHODS OF TREATING TERM AND NEAR-TERM NEONATES HAVING HYPOXIC RESPIRATORY FAILURE ASSOCIATED WITH CLINICAL OR ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION - The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.12-30-2010
20080299216DEUTERIUM-ENRICHED ARIPIPRAZOLE - The present application describes deuterium-enriched aripiprazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-04-2008
20090311341METHOD OF APPLYING A DISPERSION - Aqueous dispersions of hydrophobic silicic acid are applied using a two-substance nozzle.12-17-2009
20130071487XENON-BASED INHALABLE DRUG FOR PREVENTING ADDICTION RELAPSES IN HUMANS - The invention relates to a gas composition containing xenon gas for use in preventing the relapse of a patient who has been weaned from at least one psychotropic product which resulted in said patient becoming habituated, the xenon being administered to the patient by inhalation. The composition of the invention contains an effective volume proportion of xenon, in particular from 5 to 70% by volume of xenon. DRAWING: FIG. 03-21-2013
20110059185METHOD FOR IN-PROCESS DECONTAMINATION IN FOOD PREPARATION AND PROCESSING AND FOR REDUCING MICROBIAL CONTENT IN COSMETICS, PHARMACEUTICALS, DAILY-CARE PRODUCTS AND ANIMAL AND PLANT FOOD AND FOR TREATMENT OF SURFACES - The present invention relates to a novel method for in-process decontamination in food preparation and processing using an aqueous, health-wise non-hazardous cleaning medium. The invention further relates to a method for treating surfaces and for reducing the microbial content with an aqueous, health-wise non-hazardous medium which is more effective than conventional cleaning media.03-10-2011
20090017129Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof - This invention relates to Dead Sea anti-inflammatory medicaments or cosmetics for treatment of anti-inflammatory conditions; for example, cutaneous dryness, itching, peeling, and tightness, especially in hemodialysis patients. Methods for the preparation of and methods of treatment using these medicaments or cosmetics are also provided.01-15-2009
20100086617ANTIVIRAL FIBER, PROCESS FOR PRODUCING THE FIBER, AND TEXTILE PRODUCT COMPRISING THE FIBER - A fiber which has an excellent effect of inhibiting virus multiplication or eradication (deactivation); a process for producing the fiber; and a textile product comprising the fiber are provided. The method for producing an antiviral fiber comprises bonding a metal ion of a metal having deactivation effect to a virus and poor solubility in water to at least a part of a carboxyl group of the fiber having a cross-linked structure and having a carboxyl group in a molecule of the fiber; and then depositing fine particles of the metal and/or metal compound in the fiber by reduction and/or substitution reaction.04-08-2010
20080260857Substance and Method for Treating Neoplasms - The invention relates to substance and method for treating neoplasms in mammals. A substance for treating neoplasm comprises water comprising from 99.76 to 99.99 molecular % of light isotopologue 10-23-2008
20090263495BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS - Particular aspects provide compositions and methods for treating or preventing bacterial infection or at least one symptom related to bacterial infection, and the like in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically generated fluid (including gas-enriched electrokinetically generated fluids) as disclosed herein, the electrokinetically altered aqueous fluid suitable to alter cellular membrane structure or function sufficient to provide for modulation of intracellular signal transduction, wherein treating bacterial infection or at least one symptom related to bacterial infection is thereby afforded. In particular embodiments, the fluids are gas-enriched fluids or therapeutic compositions and methods, and include oxygen-enriched water optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the gas-enriched therapeutic compositions.10-22-2009
20080299220HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES - A waterless composition suitable for delivery of an active agent to a body surface or cavity includes a vehicle having about 70% to about 99% by weight of a hydrophilic polar solvent, said hydrophilic solvent selected from the group consisting of (i) a mixture of two or more different polyethylene glycols (PEGs), wherein at least one PEG is a high molecular weight PEG having a melting point greater than 25° C.; and (ii) propylene glycol (PG); about 0% to about 10% of at least one surface active agent; about 0% to about 5% of a polymeric agent; about 0% to about 30% of a secondary hydrophilic solvent; and about 0% to about 5% of a silicone oil; and about 3% to about 25% hydrophobic propellant. The composition is otherwise substantially free of a hydrophobic solvent and includes at least one of a surface active agent and a polymeric agent. The vehicle and the propellant are sufficiently miscible that the components may be homogeneously distributed with mild shaking.12-04-2008
20100119616HIGHLY STABLE ELECTROLYTIC WATER WITH REDUCED NMR HALF LINE WIDTH - Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from −1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.05-13-2010
20090214668PRESERVATIVE COMPOSITIONS FOR WOOD PRODUCTS - Preservative compositions for wood products are described. The compositions include at least one boron-containing material, such as but not limited to boric anhydride, and at least one silane-containing material, such as but not limited to methyltrichlorosilane. Optionally, at least one solvent, such as tetrahydrofuran, pentane, or water, may also be employed in the compositions. The compositions impart protection to the treated wood products, especially damage caused by exposure to water and insects.08-27-2009
20120288568METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION - Compounds that reduce serum retinol, serum RBP, and/or serum retinol-RBP levels may be used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods and compositions using such compounds and their derivatives to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions. Such compounds and their derivatives may be used as single agent therapy or in combination with other agents or therapies.11-15-2012
20110300231Fluid purification system - Certain disclosed embodiments concern systems and methods of preparing dialysate for use in a home dialysis system that is compact and light-weight relative to existing systems and consumes relatively low amounts of energy. The method includes coupling a household water stream to a dialysis system; filtering the water stream; heating the water stream to at least about 138 degrees Celsius in a non-batch process to produce a heated water stream; maintaining the heated water stream at or above at least about 138 degrees Celsius for at least about two seconds; cooling the heated water stream to produce a cooled water stream; ultrafiltering the cooled water stream; and mixing dialysate components into the cooled water stream in a non-batch process.12-08-2011
20110300230FLUID PURIFICATION SYSTEM - Disclosed are systems and methods of preparing dialysate for use in a home dialysis system that is compact and light-weight relative to existing systems and consumes relatively low amounts of energy. The method includes coupling a household water stream to a dialysis system; filtering the water stream; heating the water stream to at least about 138 degrees Celsius in a non-batch process to produce a heated water stream; maintaining the heated water stream at or above at least about 138 degrees Celsius for at least about two seconds; cooling the heated water stream to produce a cooled water stream; ultrafiltering the cooled water stream; and mixing dialysate components into the cooled water stream in a non-batch process.12-08-2011
20120009272Compositions and methods for creating an air release mechanism to maintain skin health - A topical composition and method for the treatment of the symptoms of diaper rashes and skin irritations by creating an air circulating mechanism comprising a) bicarbonate of soda; b) corn starch; c) citric acid; d)a carrier oil; e) a pharmaceutically acceptable moisturizer; f) fragrance oil; and g) food grade coloring. The carrier oil is selected from the group consisting of almond oil, coconut oil, sunflower oil, apricot kernel oil, avocado oil, canola oil, evening primrose oil, grapeseed oil, hazelnut oil, jojoba oil, macadamia oil, olive oil, sesame oil, rosehip seed oil, and mixtures thereof. The pharmaceutically acceptable moisturizer is either purified water or witch hazel. In its preferred embodiments, the composition can result in a loose powder for application directly to the diapered skin, an effervescent bath tablet, and as an additive to the bodyfacing layer of a diaper.01-12-2012
20090258083METHOD OF PRODUCING AND APPLICATIONS OF COMPOSITION OF HYPOCHLOROUS ACID - A method for preparing a stabilized antimicrobial hypochlorous acid solution by diluting an aged stock solution to provide a hypochlorous acid solution at a concentration of about 50 to about 7000 ppm at a pH range of about 2.8 to about 4.0. The antimicrobial hypochlorous acid solution maintains at least 75 percent of the available chlorine present over a period of about 6 months to about 12 months. The antimicrobial hypochlorous acid solution has medical applications in humans and veterinary practice, both prophylactic and therapeutic. The solution can also be used for non-medical applications in antisepsis and sterilization of surfaces.10-15-2009
20090258084Mono and Combination Therapy with a M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Cognitive Disorders in Schizophrenia - The invention relates to the use of a functional muscarinic M1/M4 receptor agonist such as the functional muscarinic M1/M4 receptor agonist or a pharmaceutically acceptable salt thereof, in particular sabcomeline or a pharmaceutically acceptable salt thereof in for the treatment of cognitive impairment in schizophrenia and to combination therapies for the treatment of cognitive impairment in schizophrenia which the functional muscarinic M1/M4 receptor agonist or a pharmaceutically acceptable salt thereof, in particular sabcomeline or a pharmaceutically acceptable salt thereof and at least one other neuroprotective agent and/or neuroleptic and/or atypical antipsyhcotic agent are administered adjunctively or simultaneously. The invention provides methods of treatment of cognitive impairment in schizophrenia utilising such therapies and such adjunctive or simultaneous therapeutic combination therapies, therapeutic combinations for use therein and pharmaceutical compositions comprising them.10-15-2009
20090263496METHOD FOR PRODUCING METAL PARTICLES, METAL PARTICLES PRODUCED THEREBY, AND THE USE THEREOF - Process for producing metal particle sols having a metal particle content of ≧1 g/l, comprising the steps of 10-22-2009
20100098775DETECTING GENETIC PREDISPOSITION TO OSTEOARTHRITIS ASSOCIATED CONDITIONS - This application relates to methods and kits for detecting predisposition to increased risk for osteoarthritis associated conditions.04-22-2010
20090274771COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS - Provided are compositions and methods for treating or preventing lung or respiratory disorders or conditions characterized by airflow obstruction or limitation, or a symptom thereof (e.g., asthma, rhinitis, allergic rhinitis (e.g. nose respiratory tract), and chronic obstructive pulmonary disease (COPD) and COPD-associated conditions (e.g., bronchitis, emphysema, asthma), emphysema, pneumonia, bronchitis, influenza, SARS, tuberculosis, and whooping cough (pertussis), and the like) in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically generated fluid (including gas-enriched electrokinetically generated fluids) as disclosed herein, the electrokinetically altered aqueous fluid suitable to alter cellular membrane structure or function sufficient to provide for modulation of intracellular signal transduction, wherein treating a lung disorder or a symptom thereof is thereby afforded. Additional aspects relate to therapeutic compositions, and combination treatment methods comprising administration of at least one electrokinetically generated fluid in combination with at least one additional therapeutic agent.11-05-2009
20090104280PHARMACEUTICAL COMPOSITIONS FOR TREATING/PREVENTING MOTOR ORGAN DISEASES - Fullerene inhibited the decrease in cell proliferation ability of chondrocytes which is observed when cultured chondrocytes are treated with a cartilage degenerating factor (IL-1β or H04-23-2009
20080213391Substance for the Treatment of Infections - The invention relates to the use of dichloric acids and the derivatives thereof for producing medicaments used for disinfecting body cavities.09-04-2008
20080213390Deuterium Depleted Water (Ddw) Using As Adjuvant In Cancer Therapy For Cytostatics Toxicity Reducing - A method is provided for utilizing Deuterium Depleted Water (DDW) as an adjuvant in cancer therapy and for reducing cytostatic toxicity. The method includes administration of DDW having a concentration of about 60 ppm, as a daily diet, to animals. The cancer therapy can include a mono-chemotherapy where a single drug or cytostatic is used or a poly-chemotherapy where more than one drug or cytostatic is used. The drug or cytostatic that are used for chemotherapy can include one or more of Cyclophosphamide, 5-Flourouracil, Farmarubicine and Vinblastine. The method can be used to treat different types of cancer.09-04-2008
20080292718Method for Suppression Appetite and Food Intake - The invention relates to method for suppressing appetite and food intake in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue 11-27-2008
20080292716Electrolytic Water and Process for Production Thereof - The present invention discloses a process for producing an electrolytic water, wherein a to-be-electrolyzed water containing less than 0.1 mM of a water-soluble inorganic salt, 0.05 to 0.5 mass % of a hydroquinone derivative and 1 to 50 mM of L-ascorbic acid or a derivative thereof is fed into a diaphragm-free electrolytic cell of continuous flow type at a flow rate of 5 to 3,000 l/min and electrolysis is conducted continuously at a current density of 0.003 to 0.1 A/cm11-27-2008
20090311340USE OF XENON AS NEUROPROTECTANT IN A NEONATAL SUBJECT - The present invention relates to the use of xenon in the preparation of a medicament for preventing and/or alleviating one or more anesthetic-induced neurological deficits in a neonatal subject. The present invention further relates to combinations of xenon and sevoflurane, and use thereof as preconditioning agents for administration prior to hypoxic-ischaemic injury.12-17-2009
20080292719Method of Treating Metabolic Syndrome - The invention relates to the method of treating metabolic syndrome in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue 11-27-2008
20080299215DEUTERIUM-ENRICHED LESTAURTINIB - The present application describes deuterium-enriched lestaurtinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-04-2008
20090074877Water containing active Hydrogen and process for producing the same - Provided are novel water containing active hydrogen wherein the content of active hydrogen is high and a process wherein such active hydrogen-containing water is produced simply at high efficiency from an inexpensive material without needing complex apparatus or special treating agents. The water containing active hydrogen of the present invention with respect to which, in an electron spin resonance spectrum pattern obtained by measuring under such a condition that immediately after generation treatment of hydrogen radicals, 25% by mass of 5,5-dimethyl-1-pyrroline-N-oxide is added to thereby stabilize hydrogen radicals, the intensities of peaks ascribed to hydrogen radicals occurring in the vicinity of 331.8 mT magnetic field strength and in the vicinity of 335.5 mT magnetic field strength are 0.03 or greater and 0.04 or greater, respectively, taking the intensity of peak ascribed to manganese as the standard sample is produced by bringing the starting water into contact with activated carbon carrying a water-insoluble ferric oxide hydrate after a magnetization treatment.03-19-2009
20100143489SYNCHRONIZED WATER AND PRODUCTION AND USE THEREOF - A synchronized water is disclosed, in which all single water molecules at the same time are arranged in an identical way to a stable homogeneous microstructure, wherein said synchronized water in a distilled condition and at atmospheric pressure has a) a density of from 0.997855 to 0.998836 g/ml at 220 C. b) a water temperature at the freezing point of from −6.7° C. to −8.2° C., c) a melting point of from 0.10 C to 0.20 C, d) a surface tension of from 72.3 to 72.7 dyn/cm at 220 C, and e) a dielectric constant of from 82.4 to 82.6 F/m, as well as a method for preparation thereof and different uses thereof.06-10-2010
20120070508Methods, Compositions, and Devices for Managing Chlorine Dioxide Release - Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, activities that can comprise and/or relate to, a composition comprising molecular matrix-residing chlorine dioxide and/or one or more hygroscopic and/or deliquescent salts.03-22-2012
20090324735MEANS AND METHOD FOR ENHANCING A HUMAN SEXUAL ACTIVITY - The invention relates to enhancing a human sexual activity. The inventive means for enhancing a human sexual activity is embodied in the form of a light water containing at least 99.739 molecular % or at least 99.760 molecular % or at least 99.774 molecular % of the lighter 12-31-2009
20090252814USE OF XENON FOR ORGAN PROTECTION - Use of xenon is described. Xenon is used as an organ and/or tissue and/or cell protectant in the manufacture of a pharmaceutical for the protection from injury of organs and/or tissue and/or cells that express HIF.10-08-2009
20090061015Regulation of Protein Activity By Reversible Acetylation - This invention discloses the first cellular acetylated substrate protein of SIRT3, Acetyl-CoA synthetase 2 (AceCS2), which is a mitochondrial matrix protein. AceCS2 is reversibly acetylated at lysine 642 (Lys642) in the active site of the enzyme. The mitochondrial sirtuin SIRT3 interacts with AceCS2 and deacetylates Lys642 both in vitro and in vivo. Deacetylation of AceCS2 by SIRT3 activates the acetyl-CoA synthetase activity of AceCS2. Thus, a mammalian sirtuin directly controls the activity of a metabolic enzyme via reversible lysine acetylation. Modulators of the acetylation status or the activity of AceCS2 are useful for the treatment of pathological conditions, such as type II diabetes, hypercholesterolemia, hyperlipidemia, and obesity.03-05-2009
20090081310METHOD FOR REMEDIATING A STRUCTURE CONTAMINATED WITH MOLD - The invention provides methods for using chlorine dioxide gas (03-26-2009
20090220616MOISTURIZING AND LUBRICATING COMPOSITIONS - The present invention is generally directed to moisturizing and lubricating compositions for use on the bodyfacing surface of an absorbent product or on one or both faces of a tissue product. The moisturizing and lubricating compositions comprise an emollient, a humectant, and immobilizing agent and a compatibilizing agent. Optionally, the moisturizing and lubricating compositions can comprise a dispersing agent.09-03-2009
20090246290Lipid metabolism improving agent containing hydrogen molecules - According to the present invention, a lipid metabolism improving agent containing hydrogen molecules that is in a liquid or gas state is provided.10-01-2009
20130216627Portable Oxygen Enrichment Device and Method of Use - Lightweight, small, portable devices and methods are disclosed that provide oxygen-enriched air using an ultra rapid adsorption cycle based on advanced molecular sieve materials.08-22-2013
20130216628COMPOSITIONS OF HYPOCHLOROUS ACID (HOCI) AND METHODS OF MANUFACTURE THEREOF - The invention generally relates to compositions of hypochlorous acid (HOCl) and methods of manufacture thereof. In certain aspects, the invention provides air-free compositions of HOCl. In other aspects, the invention provides methods of making HOCl that involve mixing together in water in an air-free environment, a compound that generates a proton (H08-22-2013
20100129464Manufacturing method and apparatus for producing substances that include negative hydrogen ion - A manufacturing method and apparatus produces various medium such as mineral substance, vitamin substance, or ceramic that include negative hydrogen icons for use by human beings and animals. In the manufacturing method, an optional mineral substance or vitamin substance as the medium in granular or powdered form is supplied to the inside of the container and filled with liquid hydrogen or hydrogen, gas. Then after leaving them in the container for a predetermined time, the medium is removed to be air dried, thereby producing the medium which is combined and included with negative hydrogen ion. Alternatively, high pressure, heat, or high voltage may be applied to the medium to contain the negative hydrogen ion in the medium.05-27-2010
20100112086ELECTROLYTICALLY REDUCED WATER, HOT WATER FOR BATHING, AND METHOD FOR SUPPRESSION OF LUMPY FAT - An electrolytically reduced water which consists of an alkali ion water prepared by ion exchange and has a dissolved hydrogen concentration of 0.20 ppm or above, an oxidation-reduction potential of −150 mV to −500 mV, and a hydrogen ion component of pH6.5-10.5 and which is quantitatively specified in the reducing power capable of inhibiting the oxidative deterioration of fat in the cutis through the elimination of active oxygen due to the characteristics of hydrogen, the oxidation-reduction potential characteristics of high reducing action, and alkaline characteristics and can activate the skin to inhibit the oxidative deterioration and suppress lumpy fat (cellulite).05-06-2010
20100297256METHODS AND COMPOSITIONS FOR INHIBITING INTEGRINS USING TELLURIUM-CONTAINING COMPOUNDS - Compositions and methods for inhibiting integrin and treating integrin-related conditions, utilizing tellurium-containing compounds, are disclosed. The tellurium-containing compounds comprise at least one tellurium dioxo moiety and may have any one of Formulae I to IV as defined in the specification. Further disclosed are compositions and methods for treating a neoplastic condition characterized by a resistance to an anti-neoplastic agent and by a high level of expression of an integrin by neoplastic cells.11-25-2010
20100316729Use of Hyperbaric Conditions to Provide Neuroprotection - Noble gases, in particular xenon and/or helium, administered under hyperbaric conditions of less than 3 atm (0.3 MPa), are used to provide neuroprotection, in particular in patients having suffered an impact trauma to the head and/or spinal column.12-16-2010
20090035383Scavenger of in vivo harmful reactive oxygen species and/or free radicals - An object of the present invention is to provide a scavenger of in vivo harmful reactive oxygen species and/or free radicals, which is capable of effectively reducing the concentrations of in vivo reactive oxygen species and/or free radicals and exhibiting given effects such as the suppression of aging process, the prevention of geriatric or lifestyle-related disease, health promotion, and the inhibition of oxidative stress by virtue of this reduction in the concentrations of reactive oxygen species and/or free radicals. The scavenger of in vivo harmful reactive oxygen species and/or free radicals of the present invention comprises a liquid or gas comprising at least a hydrogen molecule. This medium may further comprise an oxygen molecule. Furthermore, this medium may comprise water or an aqueous solution or may be a gas. The scavenger of reactive oxygen species and/or free radicals can be used in the treatment or prevention of a disorder attributed to reactive oxygen species and/or free radicals.02-05-2009
20100173008METHOD OF TREATING OR ALLEVIATING THE SYMPTOMS OF ALESION IN MAMMAL - Provided is a new use of Brown's gas, more particularly, to the use of Brown's gas for the treatment of diseases in mammals and a Brown's gas supply apparatus therefor. It is based on the assumption that the Brown's gas is a medium capable of directly supplying moisture (special form of water according to the third theory of Brown's gas) to many regions of the body via skin, etc. Various effects of the Brown's gas on the body have been demonstrated. In particular, provided is a new use of the Brown's gas for treatment or alleviation of the symptoms of a lesion in a lesional tissue, cell, or organ of a mammal. Provided is also a simple and inexpensive Brown's gas supply apparatus for supplying pure Brown's gas suitable to be applied to the human body.07-08-2010
20110086107ARGON-BASED INHALABLE GASEOUS MEDICINAL PRODUCT FOR THE TREATMENT OF NEUROINTOXICATIONS - The invention relates to the use of argon gas for producing all or part of an inhalable medicinal product intended to prevent or treat a neurointoxication in humans. The medicinal product contains argon in an effective proportion and acts on at least one brain receptor in order to regulate the functioning of dopamine-, glutamate-, serotonin-, acetylcholine-, taurine-, GABA- and/or noradrenalin-mediated neurotransmission systems. Preferably, the proportion by volume of argon in the gaseous medicinal product is between 15 and 80%. The neurointoxication is chosen from excitotoxicities engendering a state of addiction, acute cerebral accidents, neurodegenerative diseases, and psychiatric or neurological pathologies, in particular anxiety conditions, psychotic conditions, in particular schizophrenia, and epilepsy in its various forms.04-14-2011
20110177171Oxygenated Ophthalmic Compositions and Methods of Use - The present invention relates to oxygenated ophthalmic topical compositions and methods of administering oxygenated ophthalmic topical compositions. The present invention also encompasses methods for making and administering the oxygenated ophthalmic topical compositions for use in treating or ameliorating pathologic conditions, complications, diseases and symptoms related to hypoxia of the anterior eye structure, including corneal neovascularization (CNV), edema, abrasions, infections, infiltrates, dry eye syndrome, contact lens intolerance; and redness, blurred vision, discomfort, foreign body sensation, photophobia, and irritation.07-21-2011
20120201898Storage-Stable Aqueous Solutions of Chlorine Dioxide and Methods for Preparing and Using Them - The present invention is for extremely pure solutions of chlorine dioxide, methods for making such solutions and to compositions and methods for storing, shipping and using such solutions. Generally, the chlorine dioxide solutions of the invention are aqueous solutions containing about 2500 ppm or less of total impurities. The chlorine dioxide solution can be prepare by passing dilute highly pure chlorine gas through a bed of substantially solid sodium chloride and contacting the resulting chlorine dioxide gas with a liquid.08-09-2012
20120201899Storage-Stable Aqueous Solutions of Chlorine Dioxide and Methods for Preparing and Using Them - The present invention is for extremely pure solutions of chlorine dioxide, methods for making such solutions and to compositions and methods for storing, shipping and using such solutions. Generally, the chlorine dioxide solutions of the invention are aqueous solutions containing about 2500 ppm or less of total impurities. The chlorine dioxide solution can be prepare by passing dilute highly pure chlorine gas through a bed of substantially solid sodium chloride and contacting the resulting chlorine dioxide gas with a liquid.08-09-2012
20100112085AGENT FOR STIMULATING LYMPHATIC DRAINAGE, METHOD FOR OBTAINMENT THE AGENT, AND METHOD FOR USING/ADMINISTERING THE AGENT - A lymphatic drainage stimulant is disclosed, which is produced by -providing a body of drinking water that meets predetermined sanitary requirements, and -treating the water body with a baro-membranous system. The treating preferably includes passing the water through a semi-permeable reverse-osmosis membrane made with a hole size 0.0001-0.005 μm, so that the water acquires the following parameters: a redox potential ranging from +200 to +343 mV, total mineralization ranging from 25 to 130 mg/L, and pH index ranging from 6.9 to 8.3. An optional method additionally includes saturating the water with macro- and microelements. The stimulant can be administered for medical treatment of patients with chronic skin diseases, non-oncological diseases of gastrointestinal tract, and chronic obstructive bronchitis. In such case, the stimulant is taken 30-40 minutes before and 2-2.5 hours after each meal, altogether 1.5-2.5 L a day, and the first dose is taken during the morning fast.05-06-2010
20110212185WATER THAT EXPRESSES PATHOGEN-RESISTANCE GENES (PR GENE CLUSTERS) TO ENCODE PLANT IMMUNOPROTEINS, A METHOD OF PREVENTING PLANT DISEASES USING THE WATER, AND A DEVICE FOR PRODUCING THE WATER - Disclosed is a method of preventing diseases in plants which can bring about a redox reaction in the inside of plant cells thus inducing the expression of pathogen-resistance genes in the plant cells. There is no possibility that residual contents remain in soils. It is also possible to cultivate plants which are strong against diseases. By bringing water which contains reactive oxygen species and allows the reactive oxygen species to be held and to function for a long period into contact with plants, the expression of the pathogen-resistance genes which the plants possess is induced. Accordingly, the water containing reactive oxygen is absorbed into the plants to prevent diseases in plants.09-01-2011
20090317485Skin Protectant Spray Compositions - A liquid, water-repellent, substantially anhydrous, spray-pumpable skin protectant composition is disclosed. The composition is designed for spraying directly onto skin, has suitable adherence to the skin, and resists running. The composition contains one or more actives, one or more rheology modifiers, and a carrier. The rheological modifiers can be waxes and/or associative thickeners such as some forms of silica. The carrier can be mineral oil or a mineral oil replacement (e.g., isohexadecane, cyclomethicone). Film-forming components also help the composition resist running. One indication for which the composition may be formulated is diaper rash. The active ingredient for diaper rash may be dimethicone and preferably also zinc oxide.12-24-2009
20090181105METHOD OF ANTIOXIDATION, ANTIOXIDANT-FUNCTIONING WATER, AND USAGE OF THE SAME - The objective of the present invention is to provide an antioxidation method and antioxidant-functioning water that can anticipate high benchmarks of safety on the antioxidation subject such as the human body and reduced environmental burden. An antioxidation method and antioxidant-functioning water that can transform or maintain an antioxidation subject, which is in an oxidation state due to a deficiency of electrons or needs to be protected from oxidation, into a reduced state where electrons are filled by promoting the breaking reaction of molecular hydrogen used as a substrate included in the hydrogen-dissolved water into a product of active hydrogen through a process employing a catalyst, which is a precious metal colloid or a hydrogen oxidation/reduction enzyme (except for those already existing in a living organism), on the hydrogen-dissolved water.07-16-2009
20100055196SANITIZING COMPOSITION - A sanitizing composition capable of destroying pathogens present at a locus and/or of removing biofilm present at a locus (for example MRSA or 03-04-2010
20100166880Method for treatment and diagnosis of glutamate dehydrogenase disorders - Methods and compositions for diagnosis and treatment of neurodegenerative disorders are disclosed. The methods and compositions apply the discovery of the correlation between an hGDH2 gene polymorphism and the occurrence of atypical Parkinson's Disease.07-01-2010
20100189805ELECTROCHEMICALLY TREATED WATER, METHOD AND DEVICE FOR THE PRODUCTION THEREOF, AND THE USE THEREOF AS A DISINFECTION AGENT - The present invention relates to electrochemically treated water, obtainable by means of a method that is characterized by the following steps: a) electrolyzing water and b) reducing the concentrations of the oxidants created in step a). The electrochemically treated water obtained in this manner is characterized by a disinfecting effect on bacteria, bacterial spores, fungi, fungal spores, viruses, prions, or mixtures thereof. The invention further relates to water, characterized in that the same has a disinfecting effect on bacteria, bacterial spores, fungi, fungal spores, viruses, algae, prions, or mixtures thereof, that it is substantially free of disinfection agents with the exception of the oxidants related to the disinfection agents, and that it has a total concentration of oxidants of less than 20 ppm.07-29-2010
20110189302ELECTROCHEMICAL DEVICE - There is provided an automated electrochemical device for generating a biocidal output solution, said device comprising: a flow-through electrochemical cell comprising an anodic chamber and a cathodic chamber for electrolysing an electrolyte to generate an anolyte solution and a catholyte solution; characterised in that the device further comprises: (i) a reservoir for storing catholyte; and (ii) a hydraulic circuit for recirculating catholyte from the reservoir to the anolyte on start-up of the cell, wherein input of catholyte of a compensating strength to the cell anodic chamber, is arranged so as to optimise the cell anolyte pH to produce a stable output solution at the start of the electrolysis process.08-04-2011
20100028456BROAD-SPECTRUM ANTIVIRAL COMPOSITION WITH EXCELLENT PRESERVATION STABILTY - A composition for a broad-spectrum antiviral agent with excellent preservation stability, which comprises a pure chlorine dioxide solution comprising a chlorine dioxide gas dissolved therein, a chlorite, and a pH adjuster.02-04-2010
20080292720CHOLESTEROL-INTERACTING LAYERED PHYLLOSILICATES AND METHODS OF REDUCING HYPERCHOLESTEREMIA IN A MAMMAL - Layered phyllosilicates are useful for adsorbing and/or binding to cholesterol and, thereby, reducing blood cholesterol in a patient. Accordingly, provided herein is a method of reducing hypercholesteremia in a mammal comprising administering to said mammal a protonated and at least partially exfoliated layered phyllosilicate material alone and in combination with other cholesterol-reducing agents in an amount effective to reduce hypercholesteremia in said mammal.11-27-2008
20100068294Method for Preparing Ortho Silicic Acid, Ortho Silicic Acid as Obtained, and its Use - A method for preparing ortho silicic acid wherein an acid hydrolysable silicon compound is hydrolysed in an acid solution in the presence of a non-toxic solvent agent resulting in the formation of ortho silicic acid, wherein preferably the ortho silicic acid formed is contacted with a non-toxic particulate carrier, and to the use of a silicon preparation in the production of animal feed, food or food supplement, and of a pharmaceutical or cosmetic preparation.03-18-2010
20120301551COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION - The present invention relates to 2-hydroxy-alkylamino-benzoic acid derivatives and to a combination of cell necrosis inhibitor and lithium, process for the preparation of the derivatives or the combination, pharmaceutical formulation containing the derivatives or the combination, and use of the derivatives or the combination by either concomitant or sequential administration for improvement of treatment of neuronal death or neurological dysfunction. The derivatives and the combination of the present invention are useful for treating neurological diseases, such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), spinal muscular atrophy, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury or spinal cord injury; and for treating ocular diseases such as glaucoma, diabetic retinopathy or macular degeneration.11-29-2012
20110064823TRANSDERMAL DELIVERY APPARATUS AND METHOD - An apparatus and method for applying a beneficial agent to the skin is disclosed in one embodiment of the invention as including first and second chemical reactants, each being compatible with the skin. The first and second chemical reactants react with one another to generate a beneficial agent and enhance the permeability of the skin (e.g., by generating heat). The beneficial agent may then be applied to the skin while the permeability of the skin is enhanced. In selected embodiments, the first chemical reactant includes one or more metals, or alloys thereof, that are compatible (i.e., not harmful) with the skin. Similarly, in selected embodiments, the second chemical reactant may include water. In certain embodiments, the beneficial agent generated by the first and second chemical reactants includes an antioxidant such as hydrogen.03-17-2011
20130011488Systems, Methods, and Formulations for Treating Cancer - A method and compositions for treating cancer is described using at least two epigenetic modifiers. In various embodiments, hyperbaric oxygen therapy and glycolytic inhibition therapy are used as well.01-10-2013
20080260856Topical composition containing sacred water - Topical compositions having as at least one part of their composition sacred and/or holy water. These compositions are useful for imparting a spiritual sense of well-being.10-23-2008
20120207850Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Useful in Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases - The kinetic energy of liquids can be increased by several methods described in the present application. The methods include exposure to a magnetic field provided by a rotating or vibrating magnet; exposure to an electromagnetic field provided by an electrical power cord; and placement of the liquid within the vicinity of electrostatic energy and/or sound energy. A previously described method is the bubbling of electrolysis-generated water gas (Brown's Gas) into the liquid. The increased kinetic energy can be demonstrated using a previously described neutral red dye kinetic assay (NR-Kinetic assay). Energized liquids include alcohol, alcoholic beverages and water. The use of the energized solutions to enhance the alternative cellular energy (ACE) pathway in the therapy of individuals is described.08-16-2012
20080292717Highly Stable Aqueous Solution, Electrode with Nanocoating for Preparing the Solution and Method for Making this Electrode - A highly stable aqueous solution having a molecular cluster with dimensions which are small enough to ensure substantial chemical-physical stability thereof for a relatively long time. To prepare the solution a fluid treatment device is used, which comprises at least one chamber (11-27-2008
20120058197COMPOSITIONS COMPRISING WATER WITH DEUTERIUM FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES AND A PROCESS FOR THE PREPARATION THEREOF - The invention relates to pharmaceutical and food compositions for the prevention or treatment of allergic diseases and a process for the preparation thereof. The process of the invention comprises mixing water having 0.01-135 ppm deuterium content (preferably prepared by known electrolysis or distillation) with usual additives, and formulating this mixture by usual pharmaceutical or food industrial methods to pharmaceutical or food products, preferably by applying standard flavors, aromas and other additives used in the manufacturing of medicines, non-alcoholic drinks or beer.03-08-2012
20090136588Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency - The invention encompasses methods for altering food intake, modifying nutrient digestibility and altering stool quality and/or stool frequency in an animal by adjusting the balance of metabolizable cations to metabolizable anions consumed by the animal.05-28-2009
20090148538USE OF ADSORBENT CARBON MICROSPHERES TO TREAT POUCHITIS - Disclosed herein is the use of adsorbent carbon microspheres for the treatment of pouchitis.06-11-2009
20120156307MEDICAL USES OF NANOCLUSTERED WATER - The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water.06-21-2012
20110091570Compositions and Devices for Antisepsis and Anticoagulation - Disclosed herein are compositions, methods, uses, and devices having antiseptic and anticoagulation properties in a mammal. The compositions, methods, uses, and devices are based on a therapeutically effective amount of one or more N-halogenated or N,N-dihalogenated amines, analogues or derivatives thereof, or pharmaceutically acceptable salts and esters. The preferred compound is N-chlorotaurine.04-21-2011
20100291228SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS - An object of the present invention is to provide a scavenger of in vivo harmful reactive oxygen species and/or free radicals, which is capable of effectively reducing the concentrations of in vivo reactive oxygen species and/or free radicals and exhibiting given effects such as the suppression of aging process, the prevention of geriatric or lifestyle-related disease, health promotion, and the inhibition of oxidative stress by virtue of this reduction in the concentrations of reactive oxygen species and/or free radicals. The scavenger of in vivo harmful reactive oxygen species and/or free radicals of the present invention comprises a liquid or gas comprising at least a hydrogen molecule. This medium may further comprise an oxygen molecule. Furthermore, this medium may comprise water or an aqueous solution or may be a gas. The scavenger of reactive oxygen species and/or free radicals can be used in the treatment or prevention of a disorder attributed to reactive oxygen species and/or free radicals.11-18-2010
20120121722ATAZANAVIR FORMULATIONS - The present invention relates to formulations comprising atazanavir and a silicate, and the process of preparation thereof, wherein the silicate is present in the extragranular portion.05-17-2012
20120315339NITROOXY ALKANOIC ACIDS AND DERIVATIVES THEREOF IN FEED FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE - The present invention relates to a method for reducing the production of methane emanating from the digestive activities of a ruminant and or for improving ruminant animal performance by using, as active compound at least one nitrooxy alkanoic acid and/or derivative thereof, which is administrated to the animal together with the feed. The invention also relates to the use of these compounds in feed and feed additives such as premix, concentrates and total mixed ration (TMR) or in the form of a bolus.12-13-2012
20120128786Delivery System Comprising A Silicon-Containing Material - A composition comprising nanoparticles of a hydrolysable silicon-contain material for use as a delivery system for a bioactive ingredient, wherein surface of the silicon-containing material is associated with a stabilizing agent which modifies the rate of hydrolysis of the silicon-contain material and/or inhibits the rate of orthosilicic acid polymerisation and a method of promoting the controlled release of orthosilicic acid on degradation of a composition comprising nanoparticles of a hydrolysable silicon-contain material, the method involving the treatment of the surface of the silicon-containing material with a stabilizing agent to modify the rate of hydrolysis of the silicon-containing material and/or inhibit the rate of orthosilicic acid polymerisation.05-24-2012
20100209529PHARMACOLOGIC-FUNCTIONING WATER AND USAGE OF THE SAME - The present invention provides a new pharmacologic-functioning water demonstrating pharmacologic function without any side effects, and usage of the same. The pharmacologic-functioning water, which demonstrates pharmacologic function without any side effects and includes antioxidant-functioning water as an active principle containing hydrogen-dissolved water, which is made up of molecular hydrogen used as a substrate that is included in raw water, and a precious metal colloid, which is included in the hydrogen-dissolved water and catalyzes the breaking reaction of the molecular hydrogen into a product of atomic hydrogen, is used for preventing and/or treating diseases.08-19-2010
20100209528STORAGE-STABLE AQUEOUS SOLUTIONS OF CHLORINE DIOXIDE AND METHODS FOR PREPARING AND USING THEM - The present invention is for extremely pure solutions of chlorine dioxide, methods for making such solutions and to compositions and methods for storing, shipping and using such solutions. Generally, the chlorine dioxide solutions of the invention are aqueous solutions containing about 2500 ppm or less of total impurities. The chlorine dioxide solution can be prepared by passing dilute highly pure chlorine gas through a bed of substantially solid sodium chlorite and contacting the resulting chlorine dioxide gas with a liquid.08-19-2010
20100310672DISINFECTANT BASED ON AQUEOUS; HYPOCHLOROUS ACID (HOCI)-CONTAINING SOLUTIONS; METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF - Disclosed are a disinfectant based on an aqueous, hypochlorous acid-containing solution, especially in the form of an electrochemically activated, diluted water/electrolyte solution, as well as a method for producing such a disinfectant. In order to increase the stability of such a disinfectant also in case the disinfectant has a large surface, e.g. when the disinfectant is applied to surfaces, the disinfectant further contains a certain percentage of amorphous silica (SiO12-09-2010
20110183004REPELLING AGENT, BITE REPELLING AGENT AND ARTHROPOD-BORNE DISEASE PREVENTIVE AGENT - The invention provides a measure that can readily prevent arthropod-borne diseases such as malaria that are contracted by 3 to 5 hundred million people worldwide yearly and that cause death of as many as 1.5 to 2.7 million people. By spraying in advance on the skin an arthropod-borne disease preventive agent or the like comprising chlorine dioxide as an effective component thereof, it is possible to provide repelling effect against arthropods such as infected mosquitoes that bear malaria protozoa and also to prevent biting of the skin by the arthropod, thus reducing contraction of the arthropod-borne diseases.07-28-2011
20110183005PROCESS FOR THE PREPARATION OF CONCENTRATED SOLUTIONS OF STABILIZED HYPOBROMITES - The invention provides stabilized concentrated aqueous solutions of alkali hypobromites, as well as a process for the preparation of said stabilized concentrated solutions at low temperatures, comprising reacting a concentrated alkali hydroxide aqueous solution with bromine, adding to the non-stabilized reaction product an aqueous solution of a sulfamic compound to stabilize the hypobromite, and oxidizing bromide to produce additional hypobromite.07-28-2011
20110183003Liquid oral care product geared to disinfect and sterilize a toothbrush head in a collapsible condiment like package - The invention relates to an oral care liquid composition in a unique collapsible, air-tight, condiment like package geared toward sterilize and disinfect a toothbrush head.07-28-2011
20110183002Composition and method for treating ulcers - The composition for the treatment of ulcers includes ground charcoal, ground mustard seed and an edible salt dissolved or suspended in an edible oil. A single effective therapeutic dosage of the composition includes approximately 4,000 mg of the ground charcoal, approximately 2,500 mg of the ground mustard seed, approximately 550 mg of the edible salt, and approximately 15 ml of the edible oil. The effective therapeutic dosage is delivered to the patient orally, and may be provided to the patient as a tablet or capsule, or as a liquid mixture.07-28-2011
20120135085METHOD AND COMPOSITION FOR DISINFECTION AND PURIFICATION - A method and composition for a non-toxic aqueous silicon solution.05-31-2012
20120135084Use of Deuterium Oxide for Treating Viral Diseases of the Eye - The invention relates to the use of deuterium oxide for the prophylaxis and/or therapy of viral diseases of the eye.05-31-2012
20120213860XENON-BASED INHALABLE DRUG FOR TREATING OR PREVENTING INDUCED DYSKINESIA - The invention relates to the use of a gaseous drug based on gaseous xenon for inhalation for treating or preventing in mammals dyskinesia induced by a dopaminergic agonist. The invention is particularly useful for treating levodopa induced dyskinesia in patients being treated for Parkinson's disease.08-23-2012
20120164235Hydrogel formulation comprising oxidative reductive potential water - The present invention relates to a hydrogel formulation containing an oxidative reduction potential (ORP) water solution and a gelling agent. The invention further provides a method for treating or preventing a condition in a patient comprising topically administering to a patient a therapeutically effective amount of a hydrogel formulation comprising an oxidative reductive potential solution and a gelling agent. A method for promoting wound healing in a patient is also provided.06-28-2012
20100272825METHOD OF DISINFECTING CARCASSES - Animal carcasses are disinfected by applying to the surface of the animal carcass an acidified solution of chlorine dioxide. The chlorine dioxide solution should have a pH of about 2-3 and a concentration of 1-100 ppm. The contact time for the solution onto the carcass surface should be from about 5 seconds to about 60 seconds.10-28-2010
20100009008BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS - Particular aspects provide compositions and methods for treating bacterial infection or at least one symptom related to bacterial infection in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically-altered fluid (including gas-enriched electrokinetically altered fluids) which comprise an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. The electrokinetically-altered ionic fluid compositions are sufficient to provide for modulation of intracellular signal transduction, wherein treating bacterial infection or at least one symptom related to bacterial infection is thereby afforded. In particular embodiments, the fluids are gas-enriched fluids or therapeutic compositions and methods, and include oxygen-enriched ionic aqueous solutions optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the gas-enriched therapeutic compositions.01-14-2010
20090061016Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement - A seawater based dietary supplement or functional food beverage product is revealed with enhanced energy profile, antioxidant properties, flavor and health characteristics. Seawater sources are combined with extracts of green or white tea, grape seed extract, d-ribose, extract of the roots or rhizomes of 03-05-2009
20120225132Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Capable of Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases - The kinetic energy of liquids can be increased by placing the liquid in a cobalt blue glass container, which is placed in an area exposed to sunlight. This method can be used in combination with other methods known to activate the kinetic energy of a liquid, as assessed by the neutral red kinetic assay. Infrared emitting ceramic pebbles can similarly be used to activate alcohol. Activated alcohol is more effective than unprocessed alcohol were used with neutral red dye and illuminated with ultraviolet light as a means of enhancing the alternative cellular energy (ACE) pathway in the therapy of diseases.09-06-2012
20120082734HYDROGEN PRODUCTION DEVICE, HYDROGEN ADDITION DEVICE AND HYDROGEN-ADDITIVE ARTICLE - A hydrogen production device includes a reaction unit and a hydrogen collection unit. The reaction unit includes a first region, a second region and a barrier layer. The first region stores a solid-state reactant, the second region stores a liquid-state reactant, and the barrier layer separates the first region from the second region. When the barrier layer forms an opening, the solid-state reactant comes into contact and reacts with the liquid-state reactant to produce hydrogen gas. The hydrogen collection unit has at least one gas vent to lead the hydrogen gas to flow into a hydrogen acceptor via the gas vent. The hydrogen gas is allowed to flow through the hydrogen collection unit, and the liquid-state reactant is prevented from entering the hydrogen collection unit.04-05-2012
20100189804ANTIMICROBIAL CARBON BLACK DISPERSION - Disclosed is an antimicrobial carbon black dispersion which exhibits excellent dispersant properties and also inhibits microbial contamination when used in consumer products such as cosmetic formulations. Also disclosed are methods for producing and using the antimicrobial carbon black dispersion.07-29-2010
20120231088Use of Deuterium Oxide for the Treatment of Virus-Based Diseases of the Respiratory Tract - The present invention relates to the use of deuterium oxide for the prophylaxis and/or therapy of virus-based diseases of the respiratory tract.09-13-2012
20080299221Method for Decreasing Postprandial Glucose Excursion - The invention relates to the method for decreasing postprandial glucose excursion in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue 12-04-2008
20080299219DEUTERIUM-ENRICHED OXYBUTYNIN - The present application describes deuterium-enriched oxybutynin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-04-2008
20080299218DEUTERIUM-ENRICHED VALSARTAN - The present application describes deuterium-enriched valsartan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-04-2008
20080299217DEUTERIUM-ENRICHED BIFEPRUNOX - The present application describes deuterium-enriched bifeprunox, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.12-04-2008
20120328708DISINFECTANT COMPOSITION AND ITS USE IN DENTAL TREATMENT - The present invention concerns a disinfectant or antimicrobial composition for use in dental treatment, such as treatment and/or prevention of periodontitis, gingivitis or other forms of oral infection. The present Inventor found that microorganisms that infect the dental tissues and cause inflammation thereof, are susceptible to osmotic stress, to such extent that the application of a hypertonic composition is effective in curing or preventing infection and/or inflammations. It was furthermore found that these microorganisms are also susceptible to acidic stress. The present invention therefore provides compositions that induce osmotic stress in microorganisms causing infection of dental tissue when topically applied thereto, preferably osmotic as well as acidic stress. The present invention also concerns the methods and uses involving the compositions of the invention.12-27-2012
20110038947INORGANIC PHOSPHOR, OBTAINABLE BY WET MILLING - The invention relates to inorganic phosphors, obtainable by wet milling and having a particle size distribution of D90<5 μm, to a method for producing said pigments and the use thereof. The use of wet milled inorganic phosphor particles wherein 90 percent of the particles have a diameter of equal to or less than 5 μm, especially equal to or less than 3 μm, very especially equal to or less than 1 μm can provide for an improved fluorescence in contrast to the general believe.02-17-2011
20110159105PERSONAL CARE PRODUCTS CONTAINING RAINWATER - This invention relates generally to formulations and methods for improving level of moisture absorption and retention by the skin and for improving the appearance, feel, or comfort of the skin, wherein the formulations comprise pure rainwater. In another embodiment of the invention, the formulations comprise a combination of natural extracts. The present invention is a formulation made substantially without the use of synthetic chemicals and petroleum by-products, wherein the formulation is used for personal care. More specifically, the present invention is a skin care product formulation wherein 90% or more of the ingredients are natural products.06-30-2011
20100233286PREPARATIONS OF SUSPENSIONS - A method for preparing a suspension of LDH particles comprises the steps of preparing LDH precipitates by coprecipitation to form a mixture of LDH precipitates and solution; separating the LDH precipitates from the solution; washing the LDH precipitates to remove residual ions; mixing the LDH precipitates with water; and subjecting the mixture of LDH particles and water from step (d) to a hydrothermal treatment step by heating to a temperature of from greater than 80° C. to 150° C. for a period of about 1 hour to about 144 hours to form a well dispersed suspension of LDH particles in water.09-16-2010
20120087990METHOD FOR PRODUCING ACTIVE HYDROGEN-DISSOLVED WATER AND APPARATUS FOR PRODUCING THE SAME - Provided are an apparatus and method for the long-term production of a drinking water in which active hydrogen is dissolved at a high concentration.04-12-2012
20100203156XENON AS A TREATMENT FOR HEMOGLOBINOPATHY - The method disclosed herein entails treating a person, with sickle cell disease and who is suffering a pain crisis, with an effective amount of xenon, which alleviates the pain. Inhalation of xenon at subanesthetic concentrations has significant analgesic properties, which are mechanistically independent from the opioid receptor system. Inhaled xenon diminishes the propensity of sickle hemoglobin to aggregate by occupying critical internal cavities within the sickle hemoglobin molecule. Decreased hemoglobin polymerization and red blood cell sickling is beneficial during acute crisis and reduces the high incidence of sickle cell related complications after surgery.08-12-2010
20130011487FLUORINATED BLOCK CO-POLYMERS - A block co-polymer includes a water soluble carrier block; an amino acid-based or acrylic acid-based block; and the amino acid-based or acrylic acid-based block includes a fluorinated alkyl group or a fluorinated alkylene glycol group.01-10-2013
20130022686COMBINATIONS OF LIQUID FILTRATION MEDIA AND METHODS FOR ENHANCED FILTRATION OF SELECTED WATER CONTAMINANTS - By sequentially aligning various filtration media and delivery systems, enhanced synergistic reduction of water contaminants is obtained compared to the prior art or separate use of the individual media/filters. Specific filtration media are formulated with proper proportioning and sequencing to enhance the ability to reduce metals that cause staining, odors and bad taste such as iron, copper and manganese. Also disclosed is the reduction of potentially hazardous metal radionuclides metals such as uranium, iodine, cesium, plutonium and radium. Also disclosed is improved removal of heavy metals such as arsenic, lead, chromium, and mercury as well as organic compounds such as halogenated carcinogenic compounds. The present devices and methods remove specific bacteria and their toxins from water to reduce the risk of dermatitis. Thus, the present invention enhances our ability to achieving cleaner and safer water for drinking, swimming, washing, bathing and cooking.01-24-2013
20080226743Agent for Photodynamic Therapy Containing Porous Silicon and Method of Quantitative Measurement of Reactive Oxygen Species Produced Therefrom - The present invention relates to an agent for photodynamic therapy (PDT) containing porous silicon (PSi) and a method of quantitative measurement of reactive oxygen species (ROS) produced therefrom. Particularly, it is expected that the present invention will contribute to the development of cancer treatment without side effects by suggesting PSi, a safe and reliable new cancer drug that can destroy cancer cells through generating sufficient heat with little ROS produced if the PSi is used as nanobomb for a new PDT that kills cancer cells with heat or explosion. In addition, it is expected that the present invention will provide a reliable and reproducible method for quantitative measurement of a very small amount of ROS produced therefrom through an XRD analysis.09-18-2008
20130177653SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS - An object of the present invention is to provide a scavenger of in vivo harmful reactive oxygen species and/or free radicals, which is capable of effectively reducing the concentrations of in vivo reactive oxygen species and/or free radicals and exhibiting given effects such as the suppression of aging process, the prevention of geriatric or lifestyle-related disease, health promotion, and the inhibition of oxidative stress by virtue of this reduction in the concentrations of reactive oxygen species and/or free radicals. The scavenger of in vivo harmful reactive oxygen species and/or free radicals of the present invention comprises a liquid or gas comprising at least a hydrogen molecule. This medium may further comprise an oxygen molecule. Furthermore, this medium may comprise water or an aqueous solution or may be a gas. The scavenger of reactive oxygen species and/or free radicals can be used in the treatment or prevention of a disorder attributed to reactive oxygen species and/or free radicals.07-11-2013
20130177654XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY - The invention relates to a xenon-based anesthetic gas composition to be used, via inhalation, to maintain or preserve cerebral perfusion during an endarterectomy involving the clamping of the carotid artery in a mammal under general anesthesia. The xenon is preferably used in combination with at least one injectable anesthetic morphine agent such as remifentanil, sulfentanil, fentanyl, and alfentanil. Advantageously, the xenon is mixed with an oxygen-containing gas and administered to the patient after the patient has been anesthetized, put to sleep, and intubated. The use of xenon makes it possible to achieve a reduction in the pressure gradient during the clamping of the internal carotid artery relative to the usual anesthetic agents, and to achieve stable hemodynamics.07-11-2013
20130142882METHODS AND COMPOSITIONS FOR TREATMENT, MODIFICATION AND MANAGEMENT OF BONE CANCER PAIN - The present invention provides methods and compositions for treating, preventing, modifying (reducing), or managing bone cancer pain by cyclohexenone compounds.06-06-2013
20130115306TOXIN DECONTAMINANT FOOD PRODUCT AND METHOD OF TREATING DISORDERS OF THE GASTROINTESTINAL TRACT - The invention encompasses antidotal food products containing activated charcoal for ingestion into the gastrointestinal tract of a user for treating various gastrointestinal disorders. The antidotal food product is orally administered having the visual appearance and physical properties which enables the desire on the part of young children to chew and ingest the food product.05-09-2013
20130115305MICROEMULSIONS AND ITS USE FOR PREVENTING AIRWAY DISEASES - The invention relates to novel microemulsions comprising a non-polar lipid, at least one polar solvent, a surfactant, and a polar lipid. A microemulsion of these ingredients provides an environment that substantially encloses airborne particles, and it can be used for entrapping such particles. The inventive microemulsions are especially adapted for the prevention of symptoms in mammals, which are indirectly or directly caused by airborne particles. The invention further provides compositions comprising such microemulsions and methods of treatment comprising administering the same.05-09-2013
20130129837COMPOSITIONS FOR IMPROVEMENT OF WOUND HEALING - This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H05-23-2013
20130142883MEDICAL FOOD FOR THE DIETARY MANAGEMENT OF DEPRESSION AND ANXIETY AND METHODS THEREOF - A medical food for the dietary management of depression and/or anxiety includes water containing from 0.0002 to 0.0278 mol. % of isotopologue HOD, preferably, from 0.0178 to 0.0278 mol. % of isotopologue HOD. Further, a method for the dietary management of depression and/or anxiety uses the step of administering to a subject in need thereof the medical food. Further, a method of the treatment of depression includes the steps of administering to a subject an antidepressant drug and administering to the subject the medical food. Further, a method of the treatment of anxiety includes the steps of administering to a subject an antianxiety drug and administering to the subject the medical food.06-06-2013
20130142884Cream for Applying on a Body - A cream has at least two components, one of the components includes stable water clusters, and the cream is applied on a body to produce local surface effects, local deep effects, and non-local effects in the body.06-06-2013
20100278933KINASE INHIBITOR COMPOUNDS - The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating disorders, especially cancer.11-04-2010
20130149389BIOMARKERS OF LUNG FUNCTION - Cigarette smoking is a primary determinant of chronic obstructive pulmonary disease (COPD), which is the fourth leading cause of morbidity and mortality in the United States. Unique proteins associated with COPD capable of differentiating subjects likely to experience rapid (RPD) or slow (SLW) decline in lung function have been identified using comprehensive high-throughput proteomic approaches. Thirty peptides, which mapped to 21 unique proteins, were linearly associated with annualized rates of lung function decline among smokers with COPD characterized as having rapid or slow decline and smokers without COPD. Using three different statistical approaches to assess the data, the RPD and SLW groups are differentiated by 55 peptides, which mapped to 33 unique proteins. A number of the identified peptides are proteolytic fragments of proteins that are involved in the complement and/or coagulation systems, have anti-protease activity, or metabolic functions.06-13-2013
20130149388METABOLOMICS-BASED BIOMARKERS FOR LUNG FUNCTION - Chronic obstructive pulmonary disease (COPD), characterized by chronic airflow limitation, is a serious and growing public health concern. The major environmental risk factor for COPD is cigarette smoking, but the biological mechanisms underlying COPD are not well understood. Herein, proton nuclear magnetic resonance (06-13-2013
20120276217DISINFECTING FORMULATION - The present invention provides a disinfecting formulation useful, for example, for cleaning and disinfecting human or animal body parts, and in particular for disinfecting human hands. Typically, the formulation comprises alcohol, one or more essential oils comprising cineole, gelling agent and water. The invention also provides methods of disinfection of human and animal body parts and methods for preparing the formulation.11-01-2012
20120276216Therapeutic Water Treatment - A therapeutic treatment process a source for generating specific frequencies that are able to provide a concentrated specific frequency to individual molecules of a fluid such as water. The specific frequency that is applied to the individual molecules has been determined to cause the molecule to “mimic” the effect of a specific substance or to cause a cell to do so. One such mechanism is the treated molecule acting as an agonist that triggers the receptor of a cell to release the function of the cell. These cell functions may mimic such substances as oxygen, amino acids, antioxidants, as well as substances that help nerves, hormones, bones, muscle, skin, hair, eyes, digestion, sleep and many more. The effects from the substances may include without limitation non-specific effects such as relaxing, energizing, calming, anti-aging and other effects that may benefit widely disparate individuals, as well as therapeutic effects for specific diseases and conditions for specific individuals.11-01-2012
20120015043USE AND GENERATION OF OZONE AS A DISINFECTANT OF DAIRY ANIMAL TISSUES, DAIRY EQUIPMENT, AND INFRASTRUCTURE - An ozone delivery system, method, and apparatus are disclosed. Ozonated water can be used to disinfect and clean various surfaces, equipment, and animals in a dairy setting. Animals can be disinfected and protected from disease through the use of wash-pen and sprayer injections, and other footbath products. Ozone can be educted into a drop hose and a pre-dip line at periodic intervals and into a foot bath to provide refreshed ozonated water. The ozone delivery system and method sterilizes all equipment and floor surfaces without damaging diary equipment components. The system can incorporate computer-controlled options such as maintaining off gas levels, maintaining cleaning and disinfecting records, monitoring ozonated water levels, monitoring concentrations of ozone in said ozonated water, controlling entry and exit gates, controlling a drainage system, and monitoring and educting ozone in a foot bath and wash pen.01-19-2012
20120021062METHODS FOR THE ON-SITE PRODUCTION OF CHLORAMINE AND USES THEREOF - A method of producing stable disinfectant for use as a biocidal composition. The method comprises: A) providing reagents, B) asynchronously feeding the at least two of the reagents into a wide space, and C) allowing all the reagents to conic into contact and mix with each other. The reagents comprise: a) an amine source of disinfectant in concentrated form, b) an oxidizing halogen compound in concentrated form, and c) a diluent. The use of asynchronous feeding and a wide space results in a dynamic biocide regimen. This regimen results in a changing environment that infestations have difficulty adapting to. This method also imparts superior results due to the avoidance of channeling effects which would otherwise weaken the effects of the biocide.01-26-2012

Patent applications in class INORGANIC ACTIVE INGREDIENT CONTAINING

Patent applications in all subclasses INORGANIC ACTIVE INGREDIENT CONTAINING